» Articles » PMID: 17958761

Genetic Predisposition to Pancreatic Cancer: a Brief Review

Overview
Specialty Gastroenterology
Date 2007 Oct 26
PMID 17958761
Citations 18
Authors
Affiliations
Soon will be listed here.
Citing Articles

Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.

Badheeb M, Abdelrahim A, Esmail A, Umoru G, Abboud K, Al-Najjar E Curr Oncol. 2022; 29(11):8693-8719.

PMID: 36421339 PMC: 9689647. DOI: 10.3390/curroncol29110686.


Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?.

Papadakos S, Dedes N, Pergaris A, Gazouli M, Theocharis S Int J Mol Sci. 2022; 23(7).

PMID: 35408980 PMC: 8998433. DOI: 10.3390/ijms23073620.


Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy.

Roacho-Perez J, Garza-Trevino E, Delgado-Gonzalez P, G-Buentello Z, Delgado-Gallegos J, Chapa-Gonzalez C Life (Basel). 2021; 11(11).

PMID: 34833063 PMC: 8620707. DOI: 10.3390/life11111187.


Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management.

Gupta N, Yelamanchi R World J Gastroenterol. 2021; 27(23):3158-3181.

PMID: 34163104 PMC: 8218366. DOI: 10.3748/wjg.v27.i23.3158.


Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer.

Ghidini M, Lampis A, Mirchev M, Okuducu A, Ratti M, Valeri N Genes (Basel). 2021; 12(1).

PMID: 33383713 PMC: 7823781. DOI: 10.3390/genes12010033.